SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-22-099611
Filing Date
2022-04-08
Accepted
2022-04-08 07:02:26
Documents
170
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d267980d20fa.htm   iXBRL 20-F/A 5030930
  Complete submission text file 0001193125-22-099611.txt   25868111

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abcm-20211231.xsd EX-101.SCH 177975
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcm-20211231_cal.xml EX-101.CAL 44388
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcm-20211231_def.xml EX-101.DEF 586372
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcm-20211231_lab.xml EX-101.LAB 918427
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcm-20211231_pre.xml EX-101.PRE 838088
164 EXTRACTED XBRL INSTANCE DOCUMENT d267980d20fa_htm.xml XML 7909828
Mailing Address DISCOVERY DRIVE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AX
Business Address DISCOVERY DRIVE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AX 44(0)1223696000
Abcam plc (Filer) CIK: 0001492074 (see all company filings)

IRS No.: 980487031 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-39633 | Film No.: 22815385
SIC: 2836 Biological Products, (No Diagnostic Substances)